Showing 1801-1810 of 7805 results for "".
Experts React to Latest Benzene Analysis
https://practicaldermatology.com/series/dermwire-tv/experts-react-to-latest-benzene-analysis/29810/In this week's DermwireTV, Practical Dermatology Editorial Board members provide their thoughts on the recent analysis examining benzene concentrations in BPO products; Johnson & Johnson seeks new indications for IL-23 inhibitor Tremfya; and the founder and CEO of Terns discusses plans to improvPsoriasis in Sensitive Areas
https://practicaldermatology.com/topics/psoriasis/psoriasis-in-sensitive-areas/23868/Treatment updates and tips for communicating with patients.Practically Here
https://practicaldermatology.com/series/the-practical-dermatology-podcast/practically-here/18186/Discover the Practical Dermatology podcast, taking you into the world of dermatology care with in-depth conversations with physicians, medical aesthetics industry, and other healthcare experts.Navigating Industry: Tips for Successful Relationships and Partnerships
https://practicaldermatology.com/issues/january-february-2025/navigating-industry-tips-for-successful-relationships-and-partnerships/32976/Dermatology is no longer confined to the physician-patient interaction in a busy clinic, private practice office, or academic center.SCALE 2024: Dr. Hilary Baldwin’s Tips and Tricks for Treating Keloids
https://practicaldermatology.com/conferences/scale-2024/scale-2024-dr-hilary-baldwins-tips-and-tricks-for-treating-keloids/26366/Hilary E. Baldwin, MD, discusses best practices for the treatment of keloids at Music City SCALE.DermwireTV: FDA Approves Humira Biosimilar; Study Examines Trifarotene for Acne Lesions
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-fda-approves-humira-biosimilar-study-examines-trifarotene-acne-lesions/24513/In this episode of DermwireTV, the FDA approves a high-concentration Humira biosimilar; a study finds trifarotene combined with a skincare regimen was effective for acne-induced hyperpigmentation; the FDA accepts Dermavant's NDA for Vtama cream for AD; and the PA Perspective series addresses buildinHow to Discuss Isotretinoin’s Safety Profile With Acne Patients
https://practicaldermatology.com/conferences/maui-derm-2024/how-to-discuss-isotretinoins-safety-profile-with-acne-patients/20237/Acne Symposium moderator Guy Webster, MD, PhD, clinical professor of dermatology at Thomas Jefferson University, explains how he helps adolescent patients with the most severe cases of acne manage the potential side effects of isotretinoin.Aesthetic Advances: New Technology
https://practicaldermatology.com/conferences/cosmetic-surgery-forum-2022/aesthetic-advances-new-technology/20160/Suneel Chilukuri, MD discusses the benefits of some of the new devices he’s using to improve outcomes for his aesthetic patients. He says BTL’s Emface offers him the ability to tighten and tone the facial muscles and lift neck muscles. He describes the benefits of the Sylfirm X RF microneedling systUnsolicited Offers: How Should Dermatology Practice Owners Respond?
https://practicaldermatology.com/topics/practice-management/unsolicited-offers-how-should-dermatology-practice-owners-respond/23836/Unsolicited offers have become more common. Here’s what you need to know.Strategies for Maximizing the Holiday Season: Planning for Profits in 2023
https://practicaldermatology.com/topics/practice-management/strategies-for-maximizing-the-holiday-season-planning-for-profits-in-2023/23835/How treatment and product packages can benefit you and your patients.